ABOUT GATEWAY FOR CANCER RESEARCHSM

We fund clinical trials for all types of cancers and prioritize only the most cutting-edge research that can help patients TODAY. Gateway invests in next generation patient-centric cancer research in order to drive transformational advances and breakthroughs in cancer treatment.

How Gateway is Unique:

  • Patients have a voice.
  • Helping cancer patients feel better and live longer.
  • Gateway invests in breakthrough research that is both targeted and precise.
  • 99 cents of every dollar Gateway receives goes directly to fund Phase I and Phase II cancer clinical trials.

CANCER RESEARCH: FUNDED CLINICAL TRIALS

Gateway focuses exclusively on patient-centered cancer research that improves treatment outcomes and restores the cancer patients’ quality of life. 

Since its inception over 27 years ago, Gateway has funded over 170 innovative cancer research clinical trials. New trials are continuously added in a rolling grant application process.

FUND ONE DAY

Gateway only invests in Phase I and Phase II human clinical trials where true innovation and transformational discoveries happen. Phase I and II clinical trials are severely underfunded, yet have the greatest patient impact in conquering cancer.

It costs just $16.56 per patient per day in a Gateway-funded cancer clinical trial. Will you help us fund another day of research? Fund one day, one week or more!

Fund One Day

CONNECT

In the News

Gateway for Cancer Research is proud to announce a new scientific partnership with Conquer Cancer, the ASCO Foundation, establishing the Gateway Discovery Grant Program. This biennial grant will identify compelling areas of inquiry in early phase cancer research and fund the talented clinician-scientists best positioned to pursue them.

More In the News

Media

Margie Roman
Chief Marketing Officer
Margie.Roman@gatewaycr.org

More Media

Mission Partners

Facebook Twitter Instagram YouTube LinkedIn